Skip to main
APUS
APUS logo

APUS Market Capitalization Overview

Market Cap: $21.19M as of Jun 13, 2025

$21.19M
Past Month+$1.17M (5.82%)
As of Jun 13, 2025, APUS has a market capitalization of $21.19M. Over the past 30 days, its market cap has decreased by -55.46%, while in the last 12 months, it has increased by .

Market capitalization represents the total value of Apimeds Pharmaceuticals US Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

APUS Market Cap Formula = Stock Price * Shares Outstanding

The market cap of APUS helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

APUS Market Cap History

DateMarket CapChange
Jun 2, 2025$20.84M-55.46%
May 8, 2025$46.79M

APUS End of Year Market Cap History

DateMarket CapChange
2025$21.19M

FAQs About Apimeds Pharmaceuticals US Inc (APUS) Market Cap

As of Jun 13, 2025, the market capitalization of APUS is $21.19M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Apimeds Pharmaceuticals US Inc’s market capitalization has increased by 5.82%, changing from $20.02M to $21.19M as of Jun 13, 2025.

In the last 3 months, Apimeds Pharmaceuticals US Inc’s market capitalization has increased by —, changing from – to – as of –.

In the year –, Apimeds Pharmaceuticals US Inc’s market capitalization increased from – in January to – in December, reflecting a — change.

Apimeds Pharmaceuticals US Inc (APUS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.